Medlior continues to have our work featured in respected publications and this month we’re pleased to be published in Future Oncology. Our manuscript looks at First-line treatment of advanced epidermal growth factor receptor mutation positive non-small cell lung cancer: A systematic review and network meta-analysis. Read more here.
Since 2008, when Founder Tara Cowling started Medlior Health Outcomes Research, we have grown by leaps and bounds. The Medlior team now has 15 full-time staff with another 40 regular contractors - all of whom hold advanced degrees - that allow us to offer a range of...
During the 2019 annual HTAi meeting in Cologne, Germany, Medlior’s Kelly Larkin-Kaiser along with Peter O’Blenis and Jennifer Tetzlaff from Evidence Partners hosted a workshop titled: “Best Practices for Leveraging Artificial Intelligence in the Systematic Review...
Gene therapy is a growing area of interest for the treatment of several diseases. These therapies are intended to offer a one-time treatment to modify a person’s genes through a variety of mechanisms in order to treat or cure a disease. These mechanisms include: i)...
Early mortality following the diagnosis of multiple myeloma from 2011 to 2016 in Alberta, Canada: Initial results from the population-based Identifying Outcomes in Real-World Multiple Myeloma (INFORMM) study In addition to the treatment landscape results presented at...
Multiple Myeloma Treatment Landscape from 2011 to 2016 in Alberta, Canada: Results From the Population-Based “Identifying Outcomes in Real-World Multiple Myeloma” (INFORMM) Study Building on the Methodology Poster presented at the 2019 CADTH Symposium, we will be...
Building on previously published results,1,2 we are presenting results on the low-density lipoprotein (LDL-C) management in a subgroup of patients with atherosclerotic cardiovascular diseases (ASCVD) and pre-existing diabetes from Alberta, Canada at the American...
The use of Real-World Data (RWD) in health economics research has been significantly increasing over the past decade. The growing availability of longitudinal observational health data together with big-data analytics has now enabled us to go beyond the efficacy of...
Fund assists Canadian women entrepreneurs to grow their businesses and expand market opportunities Medlior Health Outcomes Research Ltd. has been selected as a recipient of the Women Entrepreneurship Fund by the Government of Canada. This unique fund provides support...
IdeNtiFying Outcomes in Real-World Multiple Myeloma (INFORMM): Insights in Methodology for Using Administrative Health Data in Alberta An ongoing study of newly-diagnosed multiple myeloma (MM) is the first of its kind in Canada to explore real-world treatments,...